COMMUNIQUÉS West-GlobeNewswire

Codexis Reports First Quarter 2024 Financial Results
02/05/2024
Q1 Total Revenue Up 32% Year-over-year, Including Product Revenue Up 14%; Company Reiterates 2024 Financial Guidance First Substantial Order for dsRNA Ligase Received from Large Pharma Customer Company is in Final [...]
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
02/05/2024
Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027 Completion of rolling biologics [...]
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
02/05/2024
Company reports $45.6 million in Q1 product-related revenue, including $28.4 million in net product sales revenue for IBSRELA and $15.2 million in net product sales revenue for XPHOZAH Company ends Q1 with approximately [...]
Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
02/05/2024
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT BURLINGAME, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today [...]
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
02/05/2024
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of [...]
Mustang Bio Announces Closing of $4 Million Public Offering
02/05/2024
Potential Additional Gross Proceeds Upon Cash Exercise of Warrants of Up to $12 Million WORCESTER, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage [...]
WW International, Inc. Announces First Quarter 2024 Results
02/05/2024
End of Period Subscribers of 4.0 million, including 91 thousand End of Period Clinical Subscribers Revenues of $206.5 million Gross margin of 66.7%; excluding the net impact of restructuring charges related to prior [...]
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
02/05/2024
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Fouad Namouni, M.D., to its Board of Directors. Dr. [...]
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
02/05/2024
Dr. Wallace will depart his role as CSO effective May 17, 2024, and will serve as a scientific advisor, including on Monte Rosa’s Scientific Advisory Board BOSTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Monte Rosa [...]
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
02/05/2024
VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first quarter 2024 financial [...]
Alignment Healthcare Reports First Quarter 2024 Results
02/05/2024
Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% y ear-over-year respectively Medicare Advantage membership grows 50.5% year-over-year to approximately 165, [...]
Ascendis Pharma Reports First Quarter 2024 Financial Results
02/05/2024
— Rollout of YORVIPATH ® initiated in Germany and Austria, with an estimated 55 doctors writing prescriptions and ~100 patients receiving commercial product as of March 31 — TransCon™ PTH (palopegteriparatide) PDUFA [...]
Goodness Growth Holdings Announces Filing of Application for Summary Determination in Litigation with Verano
02/05/2024
– Filing reflects Company’s belief that Verano’s defense against claims of unlawful conduct is without merit – – Legal filing represents a documentary record and corresponding damages analysis – MINNEAPOLIS, May 02, [...]
Clearday Announces Board Resignation of Jeff Coleman with Warm Wishes for His Future Success
02/05/2024
San Antonio, TX, May 02, 2024 (GLOBE NEWSWIRE) -- Clearday (OTCQX CLRD), a healthcare services company focused on bringing innovative products and services to the senior care industry, would like to thank Jeffrey [...]
AdCare Rhode Island Unveils Plans for New Addition After Devastating Fire
02/05/2024
NORTH KINGSTOWN, R.I., May 02, 2024 (GLOBE NEWSWIRE) -- AdCare Rhode Island, a leading addiction treatment center, announced today its plans to rebuild following a devastating fire in April of 2021. Construction on the [...]
Three-month interim report (Q1) 2024 (unaudited)
02/05/2024
Company release No. 11/2024 ALK delivers 10 % organic revenue growth with operating profit up 41 % in Q1 and upgrades outlook The growth in ALK's overall sales was primarily driven by the European tablet sales, which [...]
ALK upgrades its full-year revenue outlook
02/05/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ) today announced that the 2024 full-year financial outlook has been updated. Revenue is now expected to grow by 10-13% in local currencies (previously: 9-12%). The full-year financial [...]
AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science
02/05/2024
PRESS RELEASE THE PARIS COURT OF APPEAL CONFIRMS THE ACQUITTAL OF THE CEO OF AB SCIENCE, ALAIN MOUSSY, AND REDUCES THE AMOUNT OF THE FINANCIAL PENALTY IMPOSED ON AB SCIENCE Paris, May 2, 2024, 7pm CET AB Science SA ( [...]
AB Science : La Cour d’Appel de Paris confirme la mise hors de cause du Président Directeur Général d’AB Science, Alain Moussy, et diminue le montant de la sanction imposée à AB Science
02/05/2024
COMMUNIQUE DE PRESSE LA COUR D’APPEL DE PARIS CONFIRME LA MISE HORS DE CAUSE DU PRESIDENT DIRECTEUR GENERAL D’AB SCIENCE, ALAIN MOUSSY, ET DIMINUE LE MONTANT DE LA SANCTION IMPOSEE A AB SCIENCE Paris, 2 mai 2024, 19h AB [...]

Pages